Healthcare & Medical Devices
The FDA Wants to Cut a $636,732 Toll on Cancer Tests. An Incumbent Asked First.
Tissue tests that gate cancer drugs have sat in the FDA's hardest class since 1998. The agency wants them out, and its own safety count backs it.